SGCB expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.901200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.078800E-01
Normal-vs-Stage2
5.447600E-01
Normal-vs-Stage3
8.191600E-01
Normal-vs-Stage4
3.113400E-01
Stage1-vs-Stage2
7.605200E-01
Stage1-vs-Stage3
1.360850E-01
Stage1-vs-Stage4
3.152400E-01
Stage2-vs-Stage3
3.175600E-01
Stage2-vs-Stage4
8.079900E-02
Stage3-vs-Stage4
1.613040E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.152600E-01
Normal-vs-AfricanAmerican
3.305200E-01
Normal-vs-Asian
7.384400E-01
Caucasian-vs-AfricanAmerican
4.140600E-01
Caucasian-vs-Asian
5.657200E-01
AfricanAmerican-vs-Asian
2.893400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.836600E-01
Normal-vs-Female
3.914400E-01
Male-vs-Female
3.430600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.672000E-01
Normal-vs-Age(41-60Yrs)
2.343000E-01
Normal-vs-Age(61-80Yrs)
6.150400E-01
Normal-vs-Age(81-100Yrs)
9.093800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.987800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.307400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.581200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.168000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.162200E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.731900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.623000E-01
Normal-vs-Daily Drinker
9.318200E-01
Normal-vs-Weekly Drinker
4.888400E-01
Normal-vs-Occasional Drinker
3.712600E-01
Normal-vs-Social Drinker
4.649200E-01
Non Drinker-vs-Daily Drinker
9.467800E-01
Non Drinker-vs-Weekly Drinker
1.358590E-01
Non Drinker-vs-Occasional Drinker
4.812100E-02
Non Drinker-vs-Social Drinker
1.338630E-01
Daily Drinker-vs-Weekly Drinker
1.457590E-01
Daily Drinker-vs-Occasional Drinker
5.105700E-02
Daily Drinker-vs-Social Drinker
1.414240E-01
Weekly Drinker-vs-Occasional Drinker
4.689000E-01
Weekly Drinker-vs-Social Drinker
7.530000E-01
Occasional Drinker-vs-Social Drinker
6.906600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.822000E-01
Normal-vs-Grade 2
9.493400E-01
Normal-vs-Grade 3
9.008600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.959800E-01
Grade 1-vs-Grade 3
5.783000E-01
Grade 1-vs-Grade 4
8.822000E-01
Grade 2-vs-Grade 3
2.659600E-01
Grade 2-vs-Grade 4
9.493400E-01
Grade 3-vs-Grade 4
9.008600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.597000E-01
Normal-vs-NonDiabetic
4.709400E-01
Diabetic-vs-NonDiabetic
1.503250E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.785400E-01
Normal-vs-NoPancreatitis
5.162200E-01
Pancreatitis-vs-NoPancreatitis
2.233600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.915600E-01
Normal-vs-N1
4.855200E-01
N0-vs-N1
3.151400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.833200E-01
Normal-vs-TP53-NonMutant
4.546400E-01
TP53-Mutant-vs-TP53-NonMutant
9.883200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
